Literature DB >> 25345897

Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171.

Johannes Hainfellner1, David N Louis, Arie Perry, Pieter Wesseling.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25345897      PMCID： PMC9426753          DOI： 10.1111/bpa.12187

Source DB:  PubMed          Journal:  Brain Pathol        ISSN： 1015-6305            Impact factor:   7.611


× No keyword cloud information.
  2 in total

1.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Authors:  Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; William Pao; Dennis C Sgroi; Marian L Birkeland
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

2.  Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Authors:  Anna S Berghoff; Harald Stefanits; Adelheid Woehrer; Harald Heinzl; Matthias Preusser; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368
  2 in total
  9 in total

1.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

2.  Molecular pathological recognition of freshly excised human glioma using terahertz ATR spectroscopy.

Authors:  Ning Mu; Chuanyan Yang; Degang Xu; Shi Wang; Kang Ma; Ying Lai; Peiwen Guo; Shuixian Zhang; Yuye Wang; Hua Feng; Tunan Chen; Jianquan Yao
Journal:  Biomed Opt Express       Date:  2021-12-07       Impact factor: 3.732

3.  The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.

Authors:  Addison Quinones; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.

Authors:  Thomas R Reich; Olivier J Switzeny; Mirjam Renovanz; Clemens Sommer; Bernd Kaina; Markus Christmann; Maja T Tomicic
Journal:  Oncotarget       Date:  2017-02-28

5.  Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.

Authors:  Mingwei Zhang; Xuezhen Wang; Xiaoping Chen; Qiuyu Zhang; Jinsheng Hong
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

6.  Transcriptional Networks Identify BRPF1 as a Potential Drug Target Based on Inflammatory Signature in Primary Lower-Grade Gliomas.

Authors:  Mingyang Xia; Huiyao Chen; Tong Chen; Ping Xue; Xinran Dong; Yifeng Lin; Duan Ma; Wenhao Zhou; Wei Shi; Hao Li
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

7.  The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.

Authors:  Yunhe Han; Cunyi Zou; Chen Zhu; Tianqi Liu; Shuai Shen; Peng Cheng; Wen Cheng; Anhua Wu
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

8.  Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Authors:  Eleonora Duregon; Luca Bertero; Alessandra Pittaro; Riccardo Soffietti; Roberta Rudà; Morena Trevisan; Mauro Papotti; Laura Ventura; Rebecca Senetta; Paola Cassoni
Journal:  Oncotarget       Date:  2016-04-19

9.  Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification.

Authors:  Enkhee Ochirjav; Bayarmaa Enkhbat; Tuul Baldandorj; Gheeyoung Choe
Journal:  J Pathol Transl Med       Date:  2019-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.